Study of the Efficacy and Safety of the Drug Ingaron (Interferon-gamma) in the Treatment of Anogenital Warts

NCT05156541 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Human Papillomavirus Infection
Anogenital Warts

Interventions

DRUG: Interferon gamma human recombinant (IFN-G)

Sponsor

SPP Pharmaclon Ltd.